Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3243]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Highlights of the p-medicine project
Highlights of the p-medicine project ( )
2 Sep 2015
The p-medicine project and ECRIN
Jacques Demotes - ECRIN
The p-medicine project and ECRIN ( Jacques Demotes - ECRIN )
2 Sep 2015
Psychological support for patients with CML
Dr Silvia Riva - University of Milan, Milan, Italy
Psychological support for patients with CML ( Dr Silvia Riva - University of Milan, Milan, Italy )
17 Aug 2015
Genetics and epigenetics of lymphocyte development and transformation
Dr Stefano Casola - IFOM University of Milan, Milan, Italy
Genetics and epigenetics of lymphocyte development and transformation ( Dr Stefano Casola - IFOM University of Milan, Milan, Italy )
27 Jul 2015
New emerging treatments in multiple myeloma
Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe...
New emerging treatments in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro )
7 Jul 2015
TargomiRs show promise in phase I study of malignant mesothelioma
Prof Nico van Zandwijk - University of Sydney, Sydney, Australia
TargomiRs show promise in phase I study of malignant mesothelioma ( Prof Nico van Zandwijk - University of Sydney, Sydney, Australia )
3 Jul 2015
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL...
Dr Paula Cramer - University of Cologne, Köln, Germany
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL ( Dr Paula Cramer - University of Cologne, Köln, Germany )
30 Jun 2015
Chemoresistance and residual disease promoted by DNMT3A R882 in AML
Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL
Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )
17 Jun 2015
EHA 2015 highlights
Peter Goodwin - ecancer reporter
EHA 2015 highlights ( Peter Goodwin - ecancer reporter )
17 Jun 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015
Biomarkers for childhood relapsed acute lymphoblastic leukaemia
Prof Anthony Moorman - Newcastle University, Newcastle, UK
Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
16 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation